Gland Pharma Q2 net declines 16% to ₹163.5 cr.
1 month, 2 weeks ago

Gland Pharma Q2 net declines 16% to ₹163.5 cr.

The Hindu  

Generic injectable-focused Gland Pharma consolidated net profit declined almost 16% to ₹163.5 crore for the quarter ended September compared to the ₹194 crore in the year earlier period. The lower net profit came on a more than 2% increase in the revenue from operations at ₹1,405.8 crore. Looking ahead, we remain focused on our strategic priorities, which include entering new markets and building a solid foundation for future growth,” Executive Chairman and CEO Srinivas Sadu said in a release. A segment wise revenue break up presentation, by the company, showed a 3% increase year on year in the key U.S. market to ₹754.7 crore; a 1% decline in the contribution from Europe at ₹245.9 crore; 45% increase to ₹51.5 crore in the other core markets of Canada, Australia and New Zealand; and flattish growth in Rest of the World as well as India markets.

Crore Q2 Net  q2  net  increase  pharma  crore  1635  zealand  growth  gland  markets  cr  revenue  declines  lower  profit  core  16

History of this topic

Glenmark Pharmaceuticals Q2 results 2024 on 16 Nov, 2024: profit at ₹354.21Cr, Revenue increased by 7.06% YoY
1 month, 1 week ago

Glenmark Pharmaceuticals Q2 results 2024 on 16 Nov, 2024: profit at ₹354.21Cr, Revenue increased by 7.06% YoY

Live Mint  

Glenmark Pharmaceuticals Q2 Results 2024:Glenmark Pharmaceuticals declared its Q2 results on 14 Nov, 2024, reporting a significant turnaround with a profit of ₹354.21 crore. As of 16 Nov, 2024, Glenmark Pharmaceuticals has a market cap of ₹43,279.2 crore, with a 52-week high of ₹1,830.95 and a low of ₹746.55. The consensus recommendation among analysts as of 16 Nov, 2024, is …

Glenmark Pharma Q2 Results: Pharma major posts net profit of ₹354.48 crore, revenue up 7.5% YoY
1 month, 1 week ago

Glenmark Pharma Q2 Results: Pharma major posts net profit of ₹354.48 crore, revenue up 7.5% YoY

Live Mint  

Glenmark Pharma Q2 Results: Glenmark Pharmaceuticals Limited announced its July to September quarter results on Thursday, November 14. The company posted a ₹354.48 crore net profit in the second quarter of the financial year 2024-25. Glenmark Pharma posted a net loss of ₹180.29 crore in the same quarter the previous year, according to the company's BSE filing on Thursday. Glenmark …

Natco Pharma Q2 Results Live: Profit Rises by 83.55% YoY
1 month, 1 week ago

Natco Pharma Q2 Results Live: Profit Rises by 83.55% YoY

Live Mint  

Natco Pharma Q2 Results Live : Natco Pharma announced its Q2 results on November 12, 2024, revealing a significant growth in both topline and profit. In terms of stock performance, Natco Pharma experienced a -2.19% return over the past week; however, the company has delivered a robust 40.5% return in the last six months and an impressive 71.42% year-to-date return. …

Stocks to watch: Ambuja Cements, Maruti, Sun Pharma, M&M, Adani Power, Infosys
4 months, 3 weeks ago

Stocks to watch: Ambuja Cements, Maruti, Sun Pharma, M&M, Adani Power, Infosys

Live Mint  

Ambuja Cements: The company reported a consolidated profit of ₹646.31 crore for Q1FY25, a 28.6% YoY decline due to rising expenses and lower revenues. Tata Steel: The company reported a 51% jump in consolidated net profit to ₹960 crore for Q1FY25, up from ₹634 crore YoY, but missed analysts’ expectations of ₹1,025 crore. Redington: The company reported a 15% YoY …

Stocks to Watch: Sun Pharma, Apollo Hospitals, Muthoot Finance, Jio Financial, Tube Investments
6 months, 3 weeks ago

Stocks to Watch: Sun Pharma, Apollo Hospitals, Muthoot Finance, Jio Financial, Tube Investments

Live Mint  

Here are the top ten stocks that are likely to be in news on Friday: Sun Pharmaceutical Industries: The pharmaceutical company has agreed to a preferential offer to acquire a 14.28% stake in the Indian Foundation for Quality Management for ₹12.5 crore. Apollo Hospitals Enterprises: The company reported a consolidated net profit of ₹253.8 crore for the quarter ended March, …

Mankind Pharma share price jumps over 8% on robust Q1 results
1 year, 4 months ago

Mankind Pharma share price jumps over 8% on robust Q1 results

Live Mint  

Mankind Pharma share news: Mankind Pharma share price jumped over 8% on Thursday's trade after pharmaceutical company reported strong Q1FY24 numbers on Wednesday. Mankind Pharma share price opened at ₹1,890 apiece on BSE, and Mankind Pharma stock price was hovering near its 52-week high level. Mankind pharma Q1 results posted record quarter in all aspects. We have On the technical …

Mankind Pharma Q1 results: Profit soars 66% on strong sales
1 year, 4 months ago

Mankind Pharma Q1 results: Profit soars 66% on strong sales

Live Mint  

Mankind Pharma Ltd on Wednesday reported a 66% growth in profit for the first quarter of fiscal year 2024 on strong domestic sales. The company's total income rose to ₹2,637 crore in June quarter of the current fiscal from ₹2,196 crore in the year-ago period, Mankind Pharma said in an exchange filing. “The pharma segment outperformed the Indian pharma market …

Gland Pharma shares end three-day losing streak, up 9%; check details
1 year, 7 months ago

Gland Pharma shares end three-day losing streak, up 9%; check details

Live Mint  

Gland Pharma shares snapped a three-day losing streak and surged by almost 9%. On Monday, Gland Pharma shares tumbled by over 19% in intraday trade, reaching a 52-week low of ₹861. Further, through transactions on the open market, foreign investor Morgan Stanley sold around 0.58% of Gland Pharma. The Morgan Stanley Investment Funds Emerging Markets Equity Fund sold roughly 9.6 …

Gland Pharma Q4 net profit declines 72% year-on-year
1 year, 7 months ago

Gland Pharma Q4 net profit declines 72% year-on-year

Live Mint  

The generic injectable focused pharmaceutical company, Gland Pharma Ltd’s reported net profits at ₹78.68 Crore during Q4, saw a sharp decline of 72% over ₹285.90 Crore reported in the year-ago quarter. The India market that accounted for 8% of total revenues during Q4FY23 and witnessed a 68% year-on-year decline is sales which the company attributed to higher base of COVID …

Pharma stock may rally over 27% as brokerage sees upside
2 years, 6 months ago

Pharma stock may rally over 27% as brokerage sees upside

Live Mint  

Gland Pharma remains on track to deliver growth, but at the same time, it continues to be vigilant about not being over dependent on a specific geography, said brokerage Nirmal Bang in a note as it hosted the Gland Pharma management at its Annual Investor Conference to discuss the company’s business outlook. The brokerage house has a Buy rating on …

Sun Pharma reports Q4 net loss at ₹2,277 cr
2 years, 6 months ago

Sun Pharma reports Q4 net loss at ₹2,277 cr

The Hindu  

Sun Pharmaceutical Industries on Monday said its consolidated net loss stood at ₹2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss. For the year ended March 2022, the company reported a consolidated net profit of ₹3,273 crore. During the quarter and year ended March 2022, the company said its unit Taro Pharmaceutical …

Gland Pharma to announce four complex injectables during FY22; Q2 profit rises 38%
3 years, 2 months ago

Gland Pharma to announce four complex injectables during FY22; Q2 profit rises 38%

Live Mint  

Hyderabad-based pharmaceutical company Gland Pharma announced that it will announce four new complex injectables during the current financial year. The generic-injectable-focused company reported a 38 per cent rise in profit after tax on annual basis at ₹302.1 crore for the second quarter of financial year 2021-22, as opposed to ₹218.9 crore in the year-ago period. The company posted 30 per …

Discover Related